Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom-Reference-Cited by-同舟云学术

Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom

Published:2017-12-10 Issue:1 Volume:45 Page:37-47
ISSN:0094-2405
Container-title:Medical Physics
language:en
Short-container-title:Med. Phys.

Author:

Schneider Sergej¹²,Jølck Rasmus Irming³⁴,Troost Esther Gera Cornelia¹²⁵⁶⁷,Hoffmann Aswin Louis¹²⁵

Affiliation:

1. Institute of Radiooncology - OncoRay; Helmholtz-Zentrum Dresden-Rossendorf; Dresden Germany

2. OncoRay - National Center for Radiation Research in Oncology; Faculty of Medicine; University Hospital Carl Gustav Carus; Technische Universität Dresden; Helmholtz-Zentrum Dresden-Rossendorf; Dresden Germany

3. Nanovi Radiotherapy A/S; DK-2800 Kongens Lyngby Denmark

4. Department of Micro- and Nanotechnology; Center for Nanomedicine and Theranostics; Technical University of Denmark; Building 423 DK-2800 Kongens. Lyngby Denmark

5. Department of Radiotherapy and Radiation Oncology; Faculty of Medicine; University Hospital Carl Gustav Carus; Technische Universität Dresden; Dresden Germany

6. German Cancer Consortium (DKTK), partner site Dresden; German Cancer Research Center (DKFZ); Heidelberg Germany

7. National Center for Tumor Diseases (NCT), partner site Dresden; Dresden Germany

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mp.12670/fullpdf

Reference44 articles.

1. Locally advanced pancreatic cancer: current therapeutic approach;Cardenes;Oncol,2006

2. Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer;Combs;Strahlenther Onkol,2013

3. Utilization of intensity-modulated radiation therapy and image-guided radiation therapy in pancreatic cancer: is it benefecial?;Reese;Semin Radiat Oncol,2014

4. Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography;Horst;IJROBP,2013

5. Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation;Yamazaki;Anticancer Res,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy;Cancers;2024-01-31

2. Longitudinal analysis of T2 relaxation time variations following radiotherapy for prostate cancer;Heliyon;2024-01

3. Comparison of a Novel Liquid Fiducial Marker with Solid Markers for Image-Guided Proton Therapy of Abdominal Tumors;2024

4. Assessing Radiotherapy Responses in Low-Risk Prostate Cancer: A Longitudinal Analysis of T2 Relaxation Times;2023-07-01

5. Smart Radiotherapy Biomaterials for Image-Guided In Situ Cancer Vaccination;Nanomaterials;2023-06-12